Details for New Drug Application (NDA): 021753
✉ Email this page to a colleague
The generic ingredient in DIFFERIN is adapalene. There are twelve drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the adapalene profile page.
Summary for 021753
Tradename: | DIFFERIN |
Applicant: | Galderma Labs Lp |
Ingredient: | adapalene |
Patents: | 2 |
Suppliers and Packaging for NDA: 021753
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIFFERIN | adapalene | GEL;TOPICAL | 021753 | NDA | Galderma Laboratories, L.P. | 0299-5918 | 0299-5918-25 | 1 BOTTLE, PUMP in 1 CARTON (0299-5918-25) / 45 g in 1 BOTTLE, PUMP |
DIFFERIN | adapalene | GEL;TOPICAL | 021753 | NDA AUTHORIZED GENERIC | Mayne Pharma Commercial LLC. | 68308-666 | 68308-666-25 | 1 TUBE in 1 CARTON (68308-666-25) / 45 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 0.3% | ||||
Approval Date: | Jun 19, 2007 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 23, 2025 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TOPICAL TREATMENT OF ACNE VULGARIS | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 29, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 021753
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription